Fenster schließen  |  Fenster drucken

BCC-Studie

kleine Ă„nderung an der BCC-Studie (01.05.2019):

alt: "The study will be conducted as randomized, double blind and vehicle-controlled ( 4:1 ratio of verum (BF-200 ALA; Ameluz\u00ae) to vehicle (placebo)) clinical trial at 12 sites in the United States of America (US). Each site should randomize between 10 and 20 subjects. "

neu: "The study will be conducted as randomized, double blind and vehicle-controlled ( 4:1 ratio of verum (BF-200 ALA; Ameluz\u00ae) to vehicle (placebo)) clinical trial at 15 sites in the United States of America (US). Each site should randomize between 10 and 20 subjects. "

https://clinicaltrials.gov/ct2/show/record/NCT03573401?lupd_…

https://clinicaltrials.gov/ct2/history/NCT03573401?B=3&A=4&C…
 
aus der Diskussion: Biofrontera - Heiße Turnaround-Spekulation
Autor (Datum des Eintrages): Master-of-Disaster  (19.05.19 09:35:36)
Beitrag: 48,620 von 51,668 (ID:60597585)
Alle Angaben ohne Gewähr © wallstreet:online